Embryonic hypertension following exposure to teratogenic doses of 5-fluoro-2'-deoxyuridine.
The teratogenicity of 5-fluoro-2'-deoxyuridine (FdU) is well established. Previously, we have demonstrated that teratogenic doses of FdU produce hematomas and suggested that those hematomas produced skeletal malformations in chicken embryos. In this study, the cardiovascular effects of teratogenic doses of FdU in chicken embryos were studied. A dose of either 0.026 micrograms FdU or 0.030 micrograms FdU was injected into the yolk sacs of fertile chicken eggs containing embryos at Hamburger and Hamilton stages 17-19 of development. The embryos were then returned to the incubator. Aortic systolic and diastolic blood pressure, blood velocity and heart rate were measured at stages 21, 24 or 27 using a servonull system and Doppler ultrasound. In addition, mean arterial blood pressure, blood flow, and stroke volume were calculated from these data. Similar data were also recorded from uninjected and saline injected control embryos. Systolic and mean arterial blood pressures were significantly increased in FdU-treated embryos at stage 27. The other parameters measured or calculated were not significantly different from control embryos. Our study suggests that elevated systolic blood pressure in chicken embryos treated with FdU may lead to hematoma formation and subsequent birth defects.
Patel
V D
VD
Department of Obstetrics and Gynecology, State University of New York Health Science Center, Syracuse, New York 13210, USA.
Nolan
R S
RS
Hu
N
N
Clark
E B
EB
Hootnick
D R
DR
Levinsohn
E M
EM
Packard
D S
DS
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002642:Chick Embryo; D004625:Embryo, Nonmammalian / Q000187:drug effects* / Q000503:physiopathology; D005467:Floxuridine / Q000633:toxicity*; D006973:Hypertension / Q000139:chemically induced*; D013723:Teratogens / Q000633:toxicity*
D013723:Teratogens; D005467:Floxuridine